Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Cheng Du Sheng Nuo Biotec Co's EV-to-FCF or its related term are showing as below:
SHSE:688117'
s EV-to-FCF Range Over the Past 10 Years
Min: -1351.96 Med: -21.95 Max: 841.35
Current: 373.89
During the past 9 years, the highest EV-to-FCF of Cheng Du Sheng Nuo Biotec Co was 841.35. The lowest was -1351.96. And the median was -21.95.
SHSE:688117's EV-to-FCF is ranked worse than 96.11% of 566
companies
in the Drug Manufacturers industry
Industry Median: 20.945
vs SHSE:688117: 373.89
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cheng Du Sheng Nuo Biotec Co (SHSE:688117) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Cheng Du Sheng Nuo Biotec Co's PE Ratio (TTM) for today is calculated as:
Cheng Du Sheng Nuo Biotec Co's share price for today is ¥24.55.
Cheng Du Sheng Nuo Biotec Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.793.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Cheng Du Sheng Nuo Biotec Co EV-to-FCF Related Terms
Cheng Du Sheng Nuo Biotec Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cheng Du Sheng Nuo Biotec Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cheng Du Sheng Nuo Biotec Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cheng Du Sheng Nuo Biotec Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Cheng Du Sheng Nuo Biotec Co's EV-to-FCF falls into.
Cheng Du Sheng Nuo Biotec Co's current Enterprise Value is ¥5,712.3 Mil.
Cheng Du Sheng Nuo Biotec Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥15.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cheng Du Sheng Nuo Biotec Co (SHSE:688117) has a EV-to-FCF of 373.89 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cheng Du Sheng Nuo Biotec Co and its competitors. According to the industry distribution chart, Cheng Du Sheng Nuo Biotec Co ranks #544 out of 566 companies in the Drug Manufacturers industry, placing it in the top 96.1%.
Is Cheng Du Sheng Nuo Biotec Co's EV-to-FCF too high?
Cheng Du Sheng Nuo Biotec Co's current EV-to-FCF is 373.89. The Drug Manufacturers industry median EV-to-FCF is 20.95. Cheng Du Sheng Nuo Biotec Co's value of 373.89 is 1685.1% above this industry median. Based on the distribution chart, Cheng Du Sheng Nuo Biotec Co ranks #544 out of 566 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cheng Du Sheng Nuo Biotec Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cheng Du Sheng Nuo Biotec Co's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cheng Du Sheng Nuo Biotec Co ranks #544 out of 566 companies for EV-to-FCF. This places Cheng Du Sheng Nuo Biotec Co in the lower half of its industry. The industry median EV-to-FCF is 20.95. Cheng Du Sheng Nuo Biotec Co's value of 373.89 is 1685.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.95, based on 566 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cheng Du Sheng Nuo Biotec Co's current EV-to-FCF of 373.89 is 1685.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Cheng Du Sheng Nuo Biotec Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cheng Du Sheng Nuo Biotec Co's current EV-to-FCF is 373.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cheng Du Sheng Nuo Biotec Co stock overvalued right now?
Based on GuruFocus' analysis, Cheng Du Sheng Nuo Biotec Co (SHSE:688117) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥28.89, compared to a current price of ¥24.55 — trading 15% below its estimated fair value. The current EV-to-FCF is 373.89 and 1685.1% above the Drug Manufacturers industry median of 20.95. Cheng Du Sheng Nuo Biotec Co's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Cheng Du Sheng Nuo Biotec Co (SHSE:688117), the current EV-to-FCF is 373.89 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cheng Du Sheng Nuo Biotec Co (SHSE:688117) Overvalued in 2026?
Based on GuruFocus' analysis, Cheng Du Sheng Nuo Biotec Co stock appears to be undervalued.
The current stock price of ¥24.55 is trading 15% below its estimated GF Value™ of ¥28.89.
GuruFocus considers Cheng Du Sheng Nuo Biotec Co to be Modestly Undervalued.
Key valuation signals for SHSE:688117:
EV-to-FCF: 373.89
GF Value™: ¥28.89 vs. price of ¥24.55 (15% below fair value)
Industry Position: 1685.1% above the Drug Manufacturers median (#544 of 566)
No single metric tells the full story. See the SHSE:688117 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688117 has been successfully added to your 
